Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology

Hysterectomy Clinical Trial

— FPS  

Official title:

Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology and Evaluation of Occult Tubal Lesions Prevalence: Preliminary Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03187327
• Other study ID #: 69HCL17_0352
• Status: Completed
• Phase: N/A
• First received: June 13, 2017
• Last updated: June 13, 2017
• Start date: September 2013
• Est. completion date: January 2015

Study information

• Verified date: May 2017
• Source: Hospices Civils de Lyon
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In this prospective study, patients who underwent vaginal hysterectomy with salpingectomy or salpingo-oophorectomy were included. The objective of this study is to assess the feasibility of prophylactic salpingectomy during vaginal hysterectomy for benign pathology and the prevalence of occult tubal lesions. The hypothesis is that prophylactic salpingectomy during vaginal hysterectomy for benign pathology present a low failure rate and it makes it possible to avoid the appearance of a certain number of ovarian cancers. The prevalence of bilateral salpingectomy with or without ovariectomy and the prevalence of histopathological and immunohistochemical (p53 expression) abnormalities were evaluated.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 69
• Est. completion date: January 2015
• Est. primary completion date: November 2014
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients who underwent vaginal hysterectomy for benign pathology with salpingectomy or salpingo-oophorectomy

Related Conditions & MeSH terms

• Hysterectomy
• Salpingectomy

Locations

Country	Name	City	State
France	Hôpital Femme Mère Enfant	Bron

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Success rate of the surgical technique	prevalence of bilateral salpingectomy with or without ovariectomy	Day 0